Evidence map›Paper›PMID 41454351›Full record

ArticleMicrobial cell factories2025

Enhanced genetic stability and expression control in growth-decoupled continuous two-stage E. coli fermentations using plasmid-dependent thyA auxotrophic selection.

Florian Simon, Patrick Stargardt, Natalia Danielewicz, Florian Weiß, Johanna Berein, Gerald Striedner, Juergen Mairhofer

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Florian SimonenGenes Biotech GmbH, Muthgasse 11/2/1, 1190, Vienna, Austria.ORCID http://orcid.org/0000-0002-5441-6402
Patrick StargardtenGenes Biotech GmbH, Muthgasse 11/2/1, 1190, Vienna, Austria. patrick.stargardt@engenes.cc.ORCID http://orcid.org/0000-0003-4073-2292
Natalia DanielewiczenGenes Biotech GmbH, Muthgasse 11/2/1, 1190, Vienna, Austria.ORCID http://orcid.org/0000-0002-3886-3288
Florian WeißenGenes Biotech GmbH, Muthgasse 11/2/1, 1190, Vienna, Austria.
Johanna BereinenGenes Biotech GmbH, Muthgasse 11/2/1, 1190, Vienna, Austria.
Gerald StriednerDepartment of Biotechnology and Food Science, Institute of Bioprocess Science and Engineering, BOKU University, Muthgasse 18, 1190, Vienna, Austria.ORCID http://orcid.org/0000-0001-8366-5195
Juergen MairhoferenGenes Biotech GmbH, Muthgasse 11/2/1, 1190, Vienna, Austria.ORCID http://orcid.org/0000-0002-2686-1971

Funding

Österreichische Forschungsförderungsgesellschaft 46311684
6 · The paper itself

Abstract

Continuous two-stage E. coli fermentations offer potential for high-efficiency bioprocesses but are often limited by plasmid instability, genetic mutations, and unintended expression during seed phases. In this study, we aimed to overcome these limitations by employing a plasmid-dependent auxotrophic selection system, specifically using a thymidine auxotrophy (thyA deletion), in conjunction with a series of plasmid modifications to enhance stability and expression control. We engineered the E. coli strain enGenes-e

Indexed as

Escherichia coliPlasmidsFermentationGene Expression Regulation, BacterialGenomic InstabilityBasal expressionContinuous biomanufacturingenGenes-eXpressEscherichia coliPlasmid stabilityT7 expression systemThymidine auxotrophy

Identifiers

PMID41454351
PMCPMC12853824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.